Gene · 654
Papers3,545
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,545
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bone morphogenetic protein signaling is a possible therapeutic target in gynecologic cancer. | Cancer Sci | 2023 | 36468782 | PubTator, text mining | PubMed |
| Bone morphogenetic protein 4 is involved in cadmium-associated bone damage. | Toxicol Sci | 2023 | 36453845 | PubTator, text mining | PubMed |
| Cell-scaffold interactions in tissue engineering for oral and craniofacial reconstruction. | Bioact Mater | 2023 | 36406245 | PubTator, text mining | PubMed |
| TCDD alters essential transcriptional regulators of osteogenic differentiation in multipotent mesenchymal stem cells. | Toxicol Sci | 2023 | 36370075 | PubTator, text mining | PubMed |
| Iron metabolism disorder regulated by BMP signaling in hypoxic pulmonary hypertension. | Biochim Biophys Acta Mol Basis Dis | 2023 | 36343841 | PubTator, text mining | PubMed |
| The catabolic-to-anabolic shift seen in the canine osteoarthritic cartilage treated with knee joint distraction occurs after the distraction period. | J Orthop Translat | 2023 | 36313973 | PubTator, text mining | PubMed |
| RISING STARS: Heterogeneity and the tumor microenvironment in neuroendocrine prostate cancer. | J Endocrinol | 2023 | 36286645 | PubTator, text mining | PubMed |
| Methods to study adult hippocampal neurogenesis in humans and across the phylogeny. | Hippocampus | 2023 | 36259116 | PubTator, text mining | PubMed |
| Towards Clinical Translation of In Situ Cartilage Engineering Strategies: Optimizing the Critical Facets of a Cell-Laden Hydrogel Therapy. | Tissue Eng Regen Med | 2023 | 36244053 | PubTator, text mining | PubMed |
| Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST-CHF study. | ESC Heart Fail | 2023 | 36184749 | PubTator, text mining | PubMed |
| Bone morphogenetic protein pathway responses and alterations of osteogenesis in metastatic prostate cancers. | Cancer Rep (Hoboken) | 2023 | 36054271 | PubTator, text mining | PubMed |
| Hepcidin and Iron in Health and Disease. | Annu Rev Med | 2023 | 35905974 | PubTator, text mining | PubMed |
| Progress and prospect of technical and regulatory challenges on tissue-engineered cartilage as therapeutic combination product. | Bioact Mater | 2023 | 35846847 | PubTator, text mining | PubMed |
| The pathological risk score: A new deep learning-based signature for predicting survival in cervical cancer. | Cancer Med | 2023 | 35762423 | PubTator, text mining | PubMed |
| A Biomaterial Model to Assess the Effects of Age in Vascularization. | Cells Tissues Organs | 2023 | 35249009 | PubTator, text mining | PubMed |
| Research progress on exosomal proteins as diagnostic markers of gastric cancer (review article). | Clin Exp Med | 2023 | 35066729 | PubTator, text mining | PubMed |
| The investigation of diverse physiological and therapeutic impact of cellular-based products derived from human cumulus cells. | Turk J Biol | 2022 | 37529007 | PubTator, text mining | PubMed |
| Emerging role of hypoxia-inducible factor-1α in inflammatory autoimmune diseases: A comprehensive review. | Front Immunol | 2022 | 36761171 | PubTator, text mining | PubMed |
| RIG-I and MDA5 are modulated by bone morphogenetic protein (BMP6) and are essential for restricting Zika virus infection in human Sertoli cells. | Front Microbiol | 2022 | 36713156 | PubTator, text mining | PubMed |
| Molecular profiling of urinary extracellular vesicles in chronic kidney disease and renal fibrosis. | Front Pharmacol | 2022 | 36712680 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/654/papers?page=25